Christopher J. Pazoles
Keine laufenden Positionen mehr
Profil
Christopher J.
Pazoles worked as the Vice President-Research & Development at Novelos Therapeutics, Inc. from 2013 to 2014.
Prior to that, he held the position of Senior Vice President-Research & Development at Cellectar Biosciences, Inc. from 2005 to 2013.
From 2014 to 2019, he served as the President & Chief Drug Development Consultant at D.Houck LLC (North Carolina).
Dr. Pazoles obtained a doctorate degree from the University of Notre Dame.
Ehemalige bekannte Positionen von Christopher J. Pazoles
Unternehmen | Position | Ende |
---|---|---|
Pharmakey LLC
Pharmakey LLC Pharmaceuticals: MajorHealth Technology Pharmakey LLC develops and manufactures pharmaceutical products. It offers pharmaceutical development and due diligence consulting, outsourcing and implementation, regulatory and quality and electronic regulatory publishing services. The company was founded by David R. Houck in January 2008 nd is headquartered in Durham, NC. | Präsident | 01.04.2019 |
Novelos Therapeutics, Inc.
Novelos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Novelos Therapeutics, Inc. is a pharmaceutical company, which is engaged in the development of novel drugs for the treatment and diagnosis of cancer. It comprises of three cancer-targeted compounds: GLOW2, HOT and LIGHT, which are used for the treatment of cancer. Its therapeutic compounds directly kill cancer cells while minimizing harm to normal cells. This offers the potential for a paradigm shift in cancer therapy by providing efficacy in all three major drivers of mortality in cancer: primary tumors, metastases and stem cell-based relapse. Its LIGHT compound is a small-molecule cancer-targeted imaging agent, which is potential for selective detection of tumors and metastases in a broad range of cancers. Its HOT compound is a small-molecule, broad-spectrum, cancer-targeted molecular radio therapeutic that delivers radiation directly and selectively to cancer cells and cancer stem cells. Its GLOW2 compound is a small-molecule, broad-spectrum, cancer-targeted, non-radioactive optical imaging agent which is potential for intraoperative tumor margin illumination and non-invasive tumor imaging. The company was founded on June 21, 1996 and is headquartered in Madison, WI. | Technik-/Wissenschafts-/F&E-Leiter | 12.02.2014 |
CELLECTAR BIOSCIENCES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 30.11.2013 |
Ausbildung von Christopher J. Pazoles
University of Notre Dame | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
CELLECTAR BIOSCIENCES, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Novelos Therapeutics, Inc.
Novelos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Novelos Therapeutics, Inc. is a pharmaceutical company, which is engaged in the development of novel drugs for the treatment and diagnosis of cancer. It comprises of three cancer-targeted compounds: GLOW2, HOT and LIGHT, which are used for the treatment of cancer. Its therapeutic compounds directly kill cancer cells while minimizing harm to normal cells. This offers the potential for a paradigm shift in cancer therapy by providing efficacy in all three major drivers of mortality in cancer: primary tumors, metastases and stem cell-based relapse. Its LIGHT compound is a small-molecule cancer-targeted imaging agent, which is potential for selective detection of tumors and metastases in a broad range of cancers. Its HOT compound is a small-molecule, broad-spectrum, cancer-targeted molecular radio therapeutic that delivers radiation directly and selectively to cancer cells and cancer stem cells. Its GLOW2 compound is a small-molecule, broad-spectrum, cancer-targeted, non-radioactive optical imaging agent which is potential for intraoperative tumor margin illumination and non-invasive tumor imaging. The company was founded on June 21, 1996 and is headquartered in Madison, WI. | Health Technology |
Pharmakey LLC
Pharmakey LLC Pharmaceuticals: MajorHealth Technology Pharmakey LLC develops and manufactures pharmaceutical products. It offers pharmaceutical development and due diligence consulting, outsourcing and implementation, regulatory and quality and electronic regulatory publishing services. The company was founded by David R. Houck in January 2008 nd is headquartered in Durham, NC. | Health Technology |